biorphen 0,1 mg/ml
sintetica gmbh - germania - phenylephrinum - sol inj./perf. - 0,1mg/ml - stimulante cardiace excl. glicozizi cardiotonici med.adrenergice si dopaminergice
abecma
bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - agenți antineoplazici - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
peritol 4 mg comprimate
egis pharmaceuticals plc - cyproheptadinum - comprimate - 4 mg
oxitocină 5 ui/ml soluţie injectabilă
sc balkan pharmaceuticals srl - oxytocinum - soluţie injectabilă - 5 ui/ml
peritol comprimate 4 mg
egis pharmaceuticals plc - cyproheptadinum - comprimate - 4 mg
scandonest 3% plain
septodont - franta - mepivacainum - sol. inj. - 3% - anestezice locale amide
septanest cu adrenalina 1/200000
septodont - franta - combinatii (articainum+adrenalinum) - sol. inj. - 40mg/0,005mg/ml - anestezice locale amide
septanest cu adrenalina 1/100000
septodont - franta - combinatii (articainum+adrenalinum) - sol. inj. - 40mg/0,01mg/ml - anestezice locale amide
biorphen 10 mg/ml
sintetica gmbh - germania - phenylephrinum - sol. inj. - 10 mg/ml - stimulante cardiace excl. glicozizi cardiotonici med.adrenergice si dopaminergice
olynth duo 1 mg/ml+50 mg/ml
famar health care services madrid sau - spania - xylometazolinum+colecalciferol. resin. - spray naz.,sol. - 1mg/ml+50mg/ml - decongestionante si alte medicamente nazale de uz topic simpatomimetice, combinatii excl.corticosteroizi